These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26372519)

  • 41. Circulating endothelial progenitor cells in premature infants: is there an association with premature birth complications?
    Safranow K; Kotowski M; Lewandowska J; Machalińska A; Dziedziejko V; Czajka R; Celewicz Z; Rudnicki J; Machaliński B
    J Perinat Med; 2012 Mar; 40(4):455-62. PubMed ID: 22752779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
    Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
    Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can IL-33 and Endocan be New Markers for Retinopathy of Prematurity?
    Cakir U; Tayman C; Yucel C; Ozdemir O
    Comb Chem High Throughput Screen; 2019; 22(1):41-48. PubMed ID: 30914019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The role of circulating endothelial progenitor cells in the progression of retinopathy of prematurity--a prospective study].
    Machalińska A; Kotowski M; Safranow K; Lewandowska J; Modrzejewska M; Rudnicki J; Czajka R; Machaliński B
    Klin Oczna; 2011; 113(7-9):223-7. PubMed ID: 22256562
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations between VEGF isoforms and impending retinopathy of prematurity.
    Movsas TZ; Muthusamy A
    Int J Dev Neurosci; 2020 Nov; 80(7):586-593. PubMed ID: 32737903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prophylactic propranolol for prevention of ROP and visual outcome at 1 year (PreROP trial).
    Sanghvi KP; Kabra NS; Padhi P; Singh U; Dash SK; Avasthi BS
    Arch Dis Child Fetal Neonatal Ed; 2017 Sep; 102(5):F389-F394. PubMed ID: 28087723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reactivation of retinopathy of prematurity after ranibizumab treatment.
    Wong RK; Hubschman S; Tsui I
    Retina; 2015 Apr; 35(4):675-80. PubMed ID: 25768252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The association between serum homocysteine levels and retinopathy of prematurity.
    Sarici AM; Yetik H; Akar S; Arvas S
    J Int Med Res; 2012; 40(5):1912-8. PubMed ID: 23206475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence of retinopathy of prematurity in infants born before 27 weeks' gestation in Sweden.
    Austeng D; Källen KB; Ewald UW; Jakobsson PG; Holmström GE
    Arch Ophthalmol; 2009 Oct; 127(10):1315-9. PubMed ID: 19822848
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation between cord blood apelin and IGF-1 levels in retinopathy of prematurity.
    Cekmez F; Pirgon O; Aydemir G; Dundar B; Cekmez Y; Karaoglu A; Fidanc K; Tunc T; Aydinoz S; Karademir F; Süleymanoglu S
    Biomark Med; 2012 Dec; 6(6):821-5. PubMed ID: 23227848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation between apelin and VEGF levels in retinopathy of prematurity: a matched case-control study.
    Zhang Y; Feng J; Shao S; Mu Q; Liu J; Zeng C; Zhang X
    BMC Ophthalmol; 2022 Aug; 22(1):342. PubMed ID: 35953806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.
    Cayabyab R; Ramanathan R
    Neonatology; 2016; 109(4):369-76. PubMed ID: 27251645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin-like growth factor binding protein-3 in preterm infants with retinopathy of prematurity.
    Gharehbaghi MM; Peirovifar A; Sadeghi K; Mostafidi H
    Indian J Ophthalmol; 2012; 60(6):527-30. PubMed ID: 23202391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet mass index can be a reliable marker in predicting the prognosis of retinopathy of prematurity in very preterm infants.
    Korkmaz L; Baştuğ O; Özdemir A; Korkut S; Karaca Ç; Akın MA; Öztürk MA
    Pediatr Neonatol; 2018 Oct; 59(5):455-463. PubMed ID: 29223489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity.
    Vannay A; Dunai G; Bányász I; Szabó M; Vámos R; Treszl A; Hajdú J; Tulassay T; Vásárhelyi B
    Pediatr Res; 2005 Mar; 57(3):396-8. PubMed ID: 15635051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retinopathy of prematurity and serum level of insulin-like growth factor-1.
    Banjac L; Bokan V
    Acta Clin Croat; 2012 Jun; 51(2):209-13. PubMed ID: 23115944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between tear levels of vascular endothelial growth factor and vitamin D at retinopathy of prematurity stages in preterm infants.
    Murugeswari P; Vinekar A; Prakalapakorn SG; Anandula VR; Subramani M; Vaidya TA; Nair AP; Jayadev C; Ghosh A; Kumaramanickavel G; Shetty R; Das D
    Sci Rep; 2023 Sep; 13(1):16175. PubMed ID: 37759071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum levels of cytokines in infants treated with conbercept for retinopathy of prematurity.
    Cheng Y; Zhu X; Linghu D; Xu Y; Liang J
    Sci Rep; 2020 Jul; 10(1):12695. PubMed ID: 32728160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prorenin levels in retinopathy of prematurity.
    Yokota H; Nagaoka T; Mori F; Hikichi T; Hosokawa H; Tanaka H; Ishida Y; Suzuki F; Yoshida A
    Am J Ophthalmol; 2007 Mar; 143(3):531-3. PubMed ID: 17317409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. POSTNATAL SERUM INSULIN-LIKE GROWTH FACTOR I AND RETINOPATHY OF PREMATURITY.
    Jensen AK; Ying GS; Huang J; Quinn GE; Binenbaum G
    Retina; 2017 May; 37(5):867-872. PubMed ID: 27529840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.